FURNERI, Pio Maria
 Distribuzione geografica
Continente #
NA - Nord America 4.143
EU - Europa 3.177
AS - Asia 842
AF - Africa 152
SA - Sud America 8
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.335
Nazione #
US - Stati Uniti d'America 3.882
IT - Italia 903
IE - Irlanda 829
UA - Ucraina 769
CN - Cina 719
CA - Canada 258
RU - Federazione Russa 198
SE - Svezia 108
CI - Costa d'Avorio 103
DE - Germania 88
FR - Francia 86
GB - Regno Unito 62
SN - Senegal 42
IN - India 41
VN - Vietnam 34
CH - Svizzera 23
AT - Austria 19
PL - Polonia 18
NL - Olanda 15
GR - Grecia 14
ES - Italia 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 9
IR - Iran 9
LB - Libano 9
FI - Finlandia 7
SG - Singapore 7
BR - Brasile 6
EU - Europa 6
RE - Reunion 5
AU - Australia 4
DK - Danimarca 3
NZ - Nuova Zelanda 3
BE - Belgio 2
KR - Corea 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PA - Panama 2
PK - Pakistan 2
RS - Serbia 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
DJ - Gibuti 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JP - Giappone 1
ME - Montenegro 1
MN - Mongolia 1
MX - Messico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
Totale 8.335
Città #
Chandler 903
Dublin 828
Jacksonville 718
Nanjing 260
Cambridge 228
Lawrence 228
Andover 226
Toronto 211
Catania 191
Ashburn 168
San Mateo 148
Boardman 116
Abidjan 103
Wilmington 103
Des Moines 101
Nanchang 79
Hebei 72
Shenyang 68
Ottawa 44
Saint Petersburg 44
Dakar 42
Tianjin 40
Changsha 39
Jiaxing 38
Rome 31
Houston 29
Seattle 26
Dong Ket 24
Padova 23
Bremen 22
Norwalk 22
Vicenza 21
Washington 21
Falls Church 20
Pune 20
Jinan 19
Messina 18
Hangzhou 16
Moscow 16
Milan 15
Milazzo 15
Misterbianco 15
Palermo 15
Aci Catena 14
Beijing 13
Liberty Lake 12
Zhengzhou 12
Kochi 11
Leawood 11
Los Angeles 11
Ann Arbor 10
Augusta 10
Grafing 10
Kunming 10
Frankfurt am Main 9
Scicli 9
Den Haag 8
Mascalucia 8
Ardabil 7
Frankfurt Am Main 7
Hanoi 7
Polska 7
Viagrande 7
Aci Sant'antonio 6
Chicago 6
Dearborn 6
Edinburgh 6
London 6
Monmouth Junction 6
Pozzo Di Gotto 6
Dallas 5
Fuzhou 5
L'hay-les-roses 5
Lappeenranta 5
Turin 5
Bologna 4
Changchun 4
Mumbai 4
Ningbo 4
Niscemi 4
Paternò 4
Redwood City 4
San Francisco 4
Siracusa 4
Tours 4
Amsterdam 3
Bronte 3
Cho Ha 3
Coulommes 3
Ferrara 3
Fiorano Modenese 3
Floridia 3
Guangzhou 3
Hanover 3
Lentini 3
Melbourne 3
Nagold 3
Napoli 3
Nea Ionia 3
Paris 3
Totale 5.731
Nome #
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes 238
Antiviral activity of clofoctol in vitro [ATTIVITA ANTIVIRALE 'IN VITRO' DELL'OCTOFENE] 118
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 94
Biological properties and production of bacteriocins-like-inhibitory substances by Lactobacillus spp. strains from human vagina 88
ANALISI DELLA SEQUENZA DELLE REGIONI A MONTE DEI "PEPTIDE SEGNALE" E "RIBOSOMAL BINDING SEQUENCE" DEI GENI ERM(B) ED ERM(A) 83
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 78
SOLID LIPID NANOPARTICLES AS A STRATEGY TO IMPROVE THE IN VITRO ANTIMICROBIAL ACTIVITY OF ITRACONAZOLE. 65
Biological properties of itraconazole-SLN 64
Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis 63
Il Microbiota vaginale e le infezioni urogenitali 62
Influenza dell’associazione clotrimazolo/metronidazolo (1:5) sullo “switching” fenotipico di C. albicans 61
Antimicrobial activity of nifuratel [ATTIVITA ANTIMICROBICA DEL NIFURATEL] 60
Formulation and characterization of erythromycin–loaded Solid Lipid Nanoparticles 60
Assessment of preservative efficacy of sodium N-hydroxymethylglicinate (NIG) in drug delivery formulations for ophthalmic use 58
A method for efficient loading of ciprofloxacin hydrochloride in cationic solid lipid nanoparticles: Formulation and microbiological evaluation 58
Postbiotic Characterization in the Amensalistic Symbiosis and Correlation to the Resilience of Human Microbiota 57
Investigation on the antibacterial activity of electronic cigarette liquids (ECLs): a proof of concept study 57
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy 56
The Antimicrobial Activity of Essential Oils Against Multi-Drug-Resistance Microorganisms: A Review 55
Role of heme oxygenase-1 (HSP32) and HSP90 in glioblastoma 55
ANTI-MYCOPLASMAL ACTIVITY OF A NEW MACROLIDE - MIOCAMYCIN 53
Electronic cigarette vapour enhances pneumococcal adherence to airway epithelial cells under abnormal conditions of exposure 53
Bacteriocins, a natural weapon against bacterial contamination for greater safety and preservation of food: a review 53
Amensalistic Activity of Human Lactobacillus Strains Isolates 51
Commentary: Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine 51
Bacterial symbionts of entomopathogenic nematodes of the genus Steinernema from South Italy: phenotypic features and evolutionary implications 50
Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily) 50
Metabolic Characterization of Supernatants Produced by Lactobacillus spp. With in vitro Anti-Legionella Activity 50
Anti-Adhesion Activity of A2-type Proanthocyanidins (a Cranberry Major Component) on Uropathogenic E. coli and P. mirabilis Strains 49
Evaluation of resistance to low pH and bile salts of human Lactobacillus spp. isolates 48
Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin 48
GenBank AF422141: Mycoplasma fermentans "incognitus strain" 23S rRNA gene, partial sequence of domain 1 48
Pefloxacin mesilate and Ofloxacin-loaded polyethylcyanoacrylate nanoparticles. Characterization of the colloidal drug carrier formulation 47
In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil 46
Antimicrobial nonapeptide leucinostatin A-dependent effects on the physical properties of phospholipid model membranes 46
In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa 46
In vitro Antimycoplasmal Activity of Citrus bergamia Essential Oil and its Derivatives 46
GenBank AF131073: Mycoplasma hominis strain CT-PAF 23S ribosomal RNA gene, partial sequence 46
"Dual-drug delivery in Solid Lipid Nanoparticles: preliminary studies" 46
EPIDEMIOLOGIC SURVEY OF MYCOPLASMA-PNEUMONIAE INFECTIONS - COMPARISON BETWEEN ELISA AND OTHER SEROLOGICAL TESTS 46
Assenza di penicillino resistenza in ceppi di Streptococcus agalactiae isolati in Sicilia 46
Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis 45
Econazole-polycarbophil, a new delivery system for topical therapy: microbiological and clinical results on vaginal candidiasis 45
SOME PHARMACOKINETIC DATA ON MIOCAMYCIN .2. CONCENTRATIONS IN GYNECOLOGICAL TISSUES 45
SOME PHARMACOKINETIC DATA ON MIOCAMYCIN .1. SERUM, URINARY AND PROSTATIC LEVELS 45
Biofilm Formation by Streptococcus agalactiae Human Isolated Strains 45
Commentary: Lactobacilli dominance and vaginal pH: Why is the human vaginal microbiome unique? 45
Intracellular accumulation of ofloxacin-loaded liposmes in human synovial fibroblasts 44
C. trachomatis detection in infertile women by using a tubal cytobrush during laparoscopy 44
Inhibitory effect of Melaleuca alternifolia (tea tree oil) on influenza A/PR/8 virus replication 44
Analysis and sequencing of the attenuator region of erm(A) gene in Streptococcus pyogenes strains with constitutive or inducible phenotype 44
Biological properties of itraconazole-SLNs 44
The impact of Prulifloxacin on vaginal lactobacillus microflora:an in vivo study 43
Evaluation of antinfective activity of an association bifidobacterium/lactobacillus in mouse intestine 43
In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components 43
Correlation Between Virulence Factors and Macrolide Resistance in Streptococcus pyogenes 43
Anti-mycoplasmal activity of hydroxytyrosol 43
Correlation between PRTF1-F2 and macrolide resistance in Streptococcus pyogenes 43
Multicenter study on clinical-microbiological activity of ofloxacin in "community acquired" gynaecological infections. 43
Nuove tecniche di analisi molecolare per l'identificazione delle comunità microbiche vaginali 42
Vaginal bacterial colonisation in post menopause: focus on uropathogenes 42
Management of Aerobic Vaginitis 41
ISOLAMENTO E CARATTERIZZAZIONE DI STREPTOCOCCUS AGALACTIAE IN DONNE GRAVIDE 41
Schiff bases of N-Hydroxy-N'-Aminoguanidines as antiviral, antibacterial and anticancer agents 41
Solid Dispersions of Chitosan Glutamate for the Local Delivery of Miconazole: Characterization and In Vitro Activity 41
Spiroplasma spp.: A Plant, Arthropod, Animal and Human Pathogen 41
Solid dispersions of chitosan glutamate for local delivery of miconazole 41
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 41
Analisi retrospettiva sulla sensibilità in vitro agli antibiotici del gruppo MLS in Streptococcus agalactiae daal 1994 al 2005 41
Analysis and Sequencing of the Regulatory Region of erm(B) in Streptococcus pyogenes Strains with “Peculiar” Inducible Phenotypes 41
INFEZIONI BATTERICHE CRONICO-DEGENERATIVE: I MICOPLASMI 41
GenBank EU492925: Streptococcus pyogenes strain 3-CT leader peptide 1 (lpg1) and leader peptide 2 lpg2) genes, complete cds; and erythromycin resistance methylase [erm(A)] gene, partial cds, 41
Laparoscopy diagnosis of chlamydial salpingitis using a tubal cytobrush 41
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 40
Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook 40
Longitudinal study on the therapy of Mycoplasma pneumoniae infections with ciprofloxacin on Syrian hamsters 40
Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications 40
In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis 39
VI-5. Dosaggio microbiologico degli antibiotici 39
SEQUENZIAMENTO DEL GENOMA DI MYCOPLASMA HOMINIS: I. STRATEGIE PER IL CLONAGGIO E CREAZIONE DELLA BANCA COSMIDICA 39
Valutazione microbiologica di agenti microbiologicamente attivi veicolati mediante "drug delivery systems" (DDS) 39
Isolamento della variante "B" del gene ermTR 39
Influence of Media and Incubation Conditions on Biofilm Formation by Streptococcus agalactiae Strains 39
Probiotic Properties of Lactobacillus fermentum Strains Isolated from Human Oral Samples and Description of their Antibacterial Activity 39
Amphiphilic ion pairs of tobramycin with lipoamino acids 39
Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin 39
Colistin and Kanamycin Together in Association with Coridothymus capitatus to Enhance their Antimicrobial Activity and Fight Multidrug-Resistance Pathogens 39
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs 38
Antimycoplasmal Activity of Oleuropein 38
Relationships between hydrophobicity and biofilm formation in Streptococcus agalactiae strains 38
Antimycoplasmal activity of roxithromycin 38
GenBank AF317663: Mycoplasma hominis strain PG21/JR2 23S ribosomal RNA gene, partial sequence 38
Amphiphilic erythromycin-lipoamino acid ion-pairs: characterization and in vitro microbiological evaluation 38
Biofilm formation by invasive Streptococcus pyogenes strains 37
Analisi e sequenziamento della regione regolatrice del gene erm(A) ad espressione costitutiva o inducibile 37
Biofilm Formation by Streptococcus agalactiae Human Isolated Strains 37
Female urinary tract infections and vaginal microbiota 37
Inhibitory activity of an Enterococcus durans strain on Vibrio cholerae non-O1 37
In vitro antiviral activity of Melaleuca alternifolia essential oil 37
Efficacy of miocamycin in the therapy of non-specific genital infections (NSGI): non-gonococcal urethritis (NGU) and acute urethral syndrome (AUS) 37
Totale 4.953
Categoria #
all - tutte 28.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 5 19
2019/20201.303 522 105 70 10 97 3 94 10 156 20 162 54
2020/20211.538 41 154 165 111 409 47 122 16 139 24 216 94
2021/20221.849 221 278 35 48 272 25 274 62 179 14 76 365
2022/20232.684 246 110 42 261 285 505 13 400 651 36 89 46
2023/2024737 91 143 59 61 58 214 11 56 15 29 0 0
Totale 8.727